Can common sage extract reduce frequency, intensity of “hot flashes”?

So-called “hot flashes” are a common and annoying side effect of androgen deprivation therapy for many men with high-risk and advanced forms of prostate cancer. A new study has suggested that an extract of common, garden sage (Salvia officinalis) may be an effective dietary supplement that can significantly lower frequency and intensity of hot flashes. … READ MORE …

The management of “hot flashes” for men on ADT

Perhaps the most interesting new data from the annual meeting of the American Society of Clinical Oncology yesterday (Sunday) was a negative result from a four-arm, randomized clinical trial. … READ MORE …

Could SSRIs be used to manage hot flashes in men on ADT?

There are new data showing that the antidepressant escitalopram (Lexapro/Forest) — a selective serotonin re-uptake inhibitor or SSRI — can significantly reduce hot flashes among women undergoing menopause. If that is the case, one wonders whether drugs of this class might have a similar impact on hot flashes in men on androgen deprivation therapy (ADT). … READ MORE …

Acupuncture as a treatment for “hot flashes” associated with ADT

Many patients have sought out acupuncture as a method to gain relief from hot flashes associated with androgen deprivation therapy (ADT). However, data from prospective clinical trials is at best limited. … READ MORE …

Prostate cancer news update: Tuesday, December 22, 2009

There are three fairly significant news reports today dealing with the following issues:

  • The relationship between a family history of prostate cancer and age at diagnosis
  • The impact of RALP on selection of surgery as a first-line treatment option
  • The management of ADT-related hot flashes … READ MORE …

Your weekend news reports: March 21, 2009

This weekend’s news reports include items on:

  • Androgen pathway genes and prostate cancer risk
  • Pre-treatment PSA doubling time and prediction of Gleason score
  • The diagnosis of prostate cancer in men with a diagnosis of HG-PIN
  • Neoadjuvant hormone therapy in men undergoing brachytherapy
  • Acupuncture as a means to manage hot flashes … READ MORE …

The Wednesday news update: January 21, 2009

Today’s news includes information on:

  • The use of markers for prognosis following first-line treatment for localized prostate cancer
  • Results of a Phase II trial of neoadjuvant docetaxel + gefitinib prior to radical prostatectomy
  • Results of a Phase III trial of gabapentin in management of ADT-related “hot flashes”
  • MRI-directed HIFU in the treatment of localized prostate cancer … READ MORE …